Home
National Association for Rights Protection & Advocacy (NARPA) Conference 2012
NY Times continues spotlight on Eli Lilly's corruption involving Zyprexa
The New York Times ran a new story on 23 March 2007 that again exposes corruption by Eli Lilly in its promotion of its psychiatric drug Zyprexa. The Times has run quite a number of pieces ever since the formerly-secret Zyprexa files were exposed by PsychRights founder attorney Jim Gottstein, who leaked the documents to NY Times journalist Alex Berenson.
James B. Gottstein, a lawyer who represents the mentally ill, said the documents about Zyprexa’s side effects raised public health issues. [photo by Joshua Borough for The New York Times[
NY Times continues exposure of Eli Lilly's corrupt and illegal marketing practices involving Zyprexa
- 23 March 2007 - MindFreedom member Ben Hansen is quoted in this NY Times investigation: In Some States, Maker Oversees Use of Its Drug.
- 14 February 2007 - NY Times: Judge Rules Drug Documents Must Be Returned to Eli Lilly
- 20 January 2007 - NY Times: "States Study Marketing of Lilly Pill":
A network of five state attorneys general are probing the Zyprexa
secret files to investigate Eli Lilly's attempted cover-up of hazards
and marketing fraud.
- 15 January 2007 - NY Times: Tom Zeller, Jr. in the NY Times business section mentions MindFreedom is one of the web sites targeted by Eli Lilly for censorship in, "Documents Borne by Winds of Free Speech."
- 4 January 2007 - NY Times: "Mother Wonders if Psychosis Drug Helped Kill Son."
- 4 January 2007 - NY Times: "Lilly to Pay Up to $500 Million to Settle Claims."
- 21 December 2006 -- NY Times: "Disparity Emerges in Lilly Data on Schizophrenia Drug."
- 20 December 2006 -- NY Times: "Court Orders Lawyer to Return Documents About an Eli Lilly Drug."
- 19 December 2006 -- NY Times: Editorial blasts Eli Lilly based on leaked documents, "Playing Down the Risks of a Drug."
- 18 December 2006 -- NY Times front page article with photo of attorney who provided the Eli Lilly files to them, PsychRights founder Jim Gottstein (upper right): "Drug Files Show Maker Promoted Unapproved Use"
- 17 December 2006 -- NY Times first article to spotlight Zyprexa secret files, "Eli Lilly Said to Play Down Risk of Top Pill". Some activists are encouraging The NY Times to publish the leaked files online as a public service, in a manner similar to way The NY Times once published the Pentagon Papers.
Despite The New York Times widespread coverage of the secret files, Eli Lilly did not name The NY Times in its request for a permanent order from US District Court, although the judge himself claimed The NY Times played played an active role in obtaining the documents.
Mainstream
media is usually so silent when it comes to covering psychiatric drug
hazards, that this silence may have helped motivate the lawyer and
doctor who originally blew the whistle on Eli Lilly documents. Court
documents claim The NY Times may have offered to cover the story as long as the paper was promised an exclusive. Jim Gottstein is founder of PsychRights, which is a sponsor group of MindFreedom International.
